8-KThe WireRoutine
Bylaw Amendment · Company Update
Filed Jan 30, 2024 · 2y ago · Accession 0001104659-24-008228
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- ArriVent BioPharma, Inc.
- Ticker
- AVBP
- CIK
- 1868279
- Form type
- 8-K
- Filing date
- Jan 30, 2024
- Report date
- Jan 30, 2024
- Document
- tm2321853d25_8k.htm
- Size
- 409 KB